Cardiovascular Effectiveness of SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Routine Care of Frail People with Type 2 Diabetes

被引：0
|
作者：
Kutz, Alexander
Gopalakrishnan, Chandrasekar
Kim, Dae H.
Patorno, Elisabetta
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-1082-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1082-P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cardiovascular effectiveness of SGLT-2 inhibitors and GLP-1 receptor agonists in routine care of frail people with type 2 diabetes
    Kutz, A.
    Gopalakrishnan, C.
    Kim, D. H.
    Patorno, E.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S282 - S283
  • [2] SGLT-2 inhibitors and GLP-1 receptor agonists for Type 2 diabetes
    Davila, Esteban
    Mccormack, James
    ACADEMIC EMERGENCY MEDICINE, 2024, 31 (04) : 408 - 411
  • [3] Cardiovascular outcomes with GLP-1 receptor agonists vs. SGLT-2 inhibitors in patients with type 2 diabetes
    Norgaard, Caroline H.
    Starkopf, Liis
    Gerds, Thomas A.
    Vestergaard, Peter
    Bonde, Anders N.
    Fosbol, Emil
    Kober, Lars
    Wong, Nathan D.
    Torp-Pedersen, Christian
    Lee, Christina J-Y
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (06) : 549 - 556
  • [4] Metabolic and cardiovascular benefits with combination therapy of SGLT-2 inhibitors and GLP-1 receptor agonists in type 2 diabetes
    Singh, Awadhesh Kumar
    Singh, Ritu
    WORLD JOURNAL OF CARDIOLOGY, 2022, 14 (06): : 329 - 342
  • [5] GLP-1 receptor agonists in comparison with SGLT-2 inhibitors
    Pavlicek, Vojtech
    DIABETOLOGE, 2020, 16 (05): : 530 - 531
  • [6] SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes: BMJ Rapid Recommendation
    Arnold, Michael J.
    Buelt, Andrew
    AMERICAN FAMILY PHYSICIAN, 2022, 105 (06) : 675 - 677
  • [7] Kidney and Cardiovascular Effectiveness of SGLT2 Inhibitors vs GLP-1 Receptor Agonists in Type 2 Diabetes
    Edmonston, Daniel
    Mulder, Hillary
    Lydon, Elizabeth
    Chiswell, Karen
    Lampron, Zachary
    Shay, Christina
    Marsolo, Keith
    Shah, Raj C.
    Jones, W. Schuyler
    Gordon, Howard
    Hwang, Wenke
    Ayoub, Isabella
    Ford, Daniel
    Chamberlain, Alanna
    Rao, Ajaykumar
    Fonseca, Vivian
    Chang, Alexander
    Ahmad, Faraz
    Hung, Adriana
    Hunt, Kelly
    Butler, Javed
    Bosworth, Hayden B.
    Pagidipati, Neha
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (08) : 696 - 708
  • [8] Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study
    Baviera, Marta
    Foresta, Andreana
    Colacioppo, Pierluca
    Macaluso, Giulia
    Roncaglioni, Maria Carla
    Tettamanti, Mauro
    Fortino, Ida
    Genovese, Stefano
    Caruso, Irene
    Giorgino, Francesco
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [9] Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study
    Marta Baviera
    Andreana Foresta
    Pierluca Colacioppo
    Giulia Macaluso
    Maria Carla Roncaglioni
    Mauro Tettamanti
    Ida Fortino
    Stefano Genovese
    Irene Caruso
    Francesco Giorgino
    Cardiovascular Diabetology, 21
  • [10] Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes
    Kutz, Alexander
    Kim, Dae Hyun
    Wexler, Deborah J.
    Liu, Jun
    Schneeweiss, Sebastian
    Glynn, Robert J.
    Patorno, Elisabetta
    DIABETES CARE, 2023, 46 (11) : 2004 - 2014
12345